A total of 49 PD LRRK2 carriers were included in the analysis of clinical features, resulting from the sum of N = 40 (24F/16M) from the case series and N = 10 (6M/4F) affected living relatives, excluding N = 1 patient with clinical diagnosis of PD whose post-mortem examination revealed a PSP-like tauopathy (see Supplementary material). This evidence concerns the gene LRRK2 and supranuclear palsy, progressive, 1.